Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Goodwill (2017 - 2025)

Adma Biologics' Goodwill history spans 9 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Goodwill changed 0.0% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, changed 0.0%, while the annual FY2025 figure was $3.5 million, 0.0% changed from the prior year.
  • Goodwill reached $3.5 million in Q4 2025 per ADMA's latest filing, down from $3.5 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $3.5 million in Q4 2022 to a low of $3.5 million in Q3 2021.
  • Average Goodwill over 5 years is $3.5 million, with a median of $3.5 million recorded in 2021.
  • Peak YoY movement for Goodwill: decreased 0.85% in 2023, then rose 0.86% in 2025.
  • A 5-year view of Goodwill shows it stood at $3.5 million in 2021, then rose by 0.01% to $3.5 million in 2022, then decreased by 0.85% to $3.5 million in 2023, then changed by 0.0% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Goodwill are $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025).